Lexapro
Lundbeck cuts more jobs in Europe
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing Lexapro, Lundbeck, cuts
Lundbeck is to cut yet more jobs in Europe as the Danish pharma firm restructures its operations to focus on …
Promise for Lundbeck and Takeda’s depression drug
May 20, 2013Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly
Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …
Lundbeck moves ahead in Q1
May 3, 2013Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1
Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …
Lexapro US loss hits Lundbeck
February 7, 2013Sales and Marketing Danish, Lexapro, Lundbeck
The loss of US patent protection on antidepressant Lexapro has put a significant dent in Lundbeck’s financial performance for 2012. …
Lundbeck issues Lexapro patent warning
November 3, 2010Sales and Marketing Azilect, Cipralex, Forest Laboratories, Lexapro, Lundbeck, Xenazine
Neurological disorder specialist Lundbeck has posted a modest growth in revenue for the third quarter, but warned the looming patent …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
